Sterling Capital Management LLC Design Therapeutics, Inc. Transaction History
Sterling Capital Management LLC
- $7.74 Trillion
- Q3 2024
A detailed history of Sterling Capital Management LLC transactions in Design Therapeutics, Inc. stock. As of the latest transaction made, Sterling Capital Management LLC holds 102 shares of DSGN stock, worth $765. This represents 0.0% of its overall portfolio holdings.
Number of Shares
102Holding current value
$765% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding DSGN
# of Institutions
106Shares Held
31.7MCall Options Held
1.1KPut Options Held
21.3K-
Sr One Capital Management, LP6.53MShares$48.9 Million11.88% of portfolio
-
Logos Global Management LP San Francisco, CA4.22MShares$31.6 Million3.0% of portfolio
-
Black Rock Inc. New York, NY2.3MShares$17.3 Million0.0% of portfolio
-
Baker Bros. Advisors LP New York, NY1.74MShares$13.1 Million0.1% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct1.6MShares$12 Million0.02% of portfolio
About Design Therapeutics, Inc.
- Ticker DSGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,807,900
- Market Cap $419M
- Description
- Design Therapeutics, Inc. a preclinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of genetic diseases caused by nucleotide repeat expansions. The company's portfolio of products comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ syste...